Page last updated: 2024-08-23

colforsin and peptide phi

colforsin has been researched along with peptide phi in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19905 (83.33)18.7374
1990's1 (16.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bjøro, T; Gautvik, KM; Gordeladze, J; Haug, E; Iversen, JG; Ostberg, BC; Sand, O; Torjesen, PA1
Wiik, P1
Bollinger, DW; Toews, ML; Turner, JT1
O'Dorisio, MS; Vassalo, LM; Wenger, GD; Wood, CL1
Beinfeld, MC; Eiden, LE; Moskal, JR; Pruss, RM1
Egan, JJ; Gardner, JD; Jensen, RT; Slimak, GG; Stark, HA1

Other Studies

6 other study(ies) available for colforsin and peptide phi

ArticleYear
Vasoactive intestinal peptide and peptide with N-terminal histidine and C-terminal isoleucine increase prolactin secretion in cultured rat pituitary cells (GH4C1) via a cAMP-dependent mechanism which involves transient elevation of intracellular Ca2+.
    Molecular and cellular endocrinology, 1987, Volume: 49, Issue:2-3

    Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adenylyl Cyclases; Animals; Calcium; Cell Membrane; Cells, Cultured; Colforsin; Cyclic AMP; Membrane Potentials; Peptide PHI; Pituitary Gland; Prolactin; Rats; Secretory Rate; Thyrotropin-Releasing Hormone; Vasoactive Intestinal Peptide; Verapamil

1987
Vasoactive intestinal peptide inhibits the respiratory burst in human monocytes by a cyclic AMP-mediated mechanism.
    Regulatory peptides, 1989, Volume: 25, Issue:2

    Topics: 1-Methyl-3-isobutylxanthine; Cells, Cultured; Colforsin; Cyclic AMP; Humans; Monocytes; Oxygen Consumption; Peptide PHI; Secretin; Vasoactive Intestinal Peptide

1989
Vasoactive intestinal peptide receptor/adenylate cyclase system: differences between agonist- and protein kinase C-mediated desensitization and further evidence for receptor internalization.
    The Journal of pharmacology and experimental therapeutics, 1988, Volume: 247, Issue:2

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenylyl Cyclases; Alkaloids; Animals; Cell Line; Colforsin; Cyclic AMP; Dose-Response Relationship, Drug; Isoquinolines; Peptide PHI; Piperazines; Protein Kinase C; Receptors, Gastrointestinal Hormone; Receptors, Vasoactive Intestinal Peptide; Staurosporine; Tetradecanoylphorbol Acetate; Vasoactive Intestinal Peptide

1988
Cyclic AMP-dependent protein kinase in Molt 4b lymphoblasts: identification by photoaffinity labeling and activation in intact cells by vasoactive intestinal polypeptide (VIP) and peptide histidine isoleucine (PHI).
    Journal of immunology (Baltimore, Md. : 1950), 1985, Volume: 134, Issue:6

    Topics: Adenylyl Cyclases; Affinity Labels; Cell Extracts; Cell Line; Colforsin; Cyclic AMP; Diterpenes; Enzyme Activation; Humans; Lymphocytes; Peptide PHI; Peptides; Phosphorylation; Protein Kinases; Vasoactive Intestinal Peptide

1985
Specific regulation of vasoactive intestinal polypeptide biosynthesis by phorbol ester in bovine chromaffin cells.
    Endocrinology, 1985, Volume: 117, Issue:3

    Topics: Animals; Cattle; Cells, Cultured; Chromaffin Granules; Chromaffin System; Colforsin; Diterpenes; Dose-Response Relationship, Drug; Enkephalin, Methionine; Enkephalins; Peptide Biosynthesis; Peptide PHI; Phorbols; Protein Precursors; RNA, Messenger; Tetradecanoylphorbol Acetate; Time Factors; Vasoactive Intestinal Peptide

1985
Effect of verapamil on the cyclic AMP-mediated pathway for amylase secretion in rat pancreatic acini.
    Pancreas, 1993, Volume: 8, Issue:2

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Amylases; Animals; Colforsin; Cyclic AMP; Intercellular Signaling Peptides and Proteins; Male; Pancreas; Peptide PHI; Peptides; Rats; Rats, Sprague-Dawley; Secretin; Vasoactive Intestinal Peptide; Verapamil

1993